Gongwin Biopharm Holdings Statistics

Total Valuation

TPEX:6617 has a market cap or net worth of TWD 10.45 billion. The enterprise value is 8.36 billion.

Market Cap	10.45B
Enterprise Value	8.36B

Important Dates

The last earnings date was Thursday, April 17, 2025.

Earnings Date	Apr 17, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6617 has 126.06 million shares outstanding. The number of shares has increased by 6.64% in one year.

Current Share Class	n/a
Shares Outstanding	126.06M
Shares Change (YoY)	+6.64%
Shares Change (QoQ)	-0.51%
Owned by Insiders (%)	23.73%
Owned by Institutions (%)	0.04%
Float	58.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	326.16
PB Ratio	3.37
P/TBV Ratio	3.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-101.29
EV / Sales	260.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.51

Financial Position

The company has a current ratio of 13.36, with a Debt / Equity ratio of 0.04.

Current Ratio	13.36
Quick Ratio	12.27
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.43
Interest Coverage	-37.67

Financial Efficiency

Return on equity (ROE) is -4.17% and return on invested capital (ROIC) is -4.39%.

Return on Equity (ROE)	-4.17%
Return on Assets (ROA)	-4.14%
Return on Invested Capital (ROIC)	-4.39%
Return on Capital Employed (ROCE)	-5.06%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.01
Inventory Turnover	3.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.33% in the last 52 weeks. The beta is 0.56, so TPEX:6617's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	-54.33%
50-Day Moving Average	99.90
200-Day Moving Average	112.86
Relative Strength Index (RSI)	43.27
Average Volume (20 Days)	204,098

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6617 had revenue of TWD 32.04 million and -82.55 million in losses. Loss per share was -0.68.

Revenue	32.04M
Gross Profit	8.68M
Operating Income	-162.06M
Pretax Income	-91.86M
Net Income	-82.55M
EBITDA	-153.87M
EBIT	-162.06M
Loss Per Share	-0.68

Full Income Statement

Balance Sheet

The company has 2.21 billion in cash and 126.75 million in debt, giving a net cash position of 2.08 billion or 16.52 per share.

Cash & Cash Equivalents	2.21B
Total Debt	126.75M
Net Cash	2.08B
Net Cash Per Share	16.52
Equity (Book Value)	3.10B
Book Value Per Share	24.64
Working Capital	2.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -87.41 million and capital expenditures -205.89 million, giving a free cash flow of -293.30 million.

Operating Cash Flow	-87.41M
Capital Expenditures	-205.89M
Free Cash Flow	-293.30M
FCF Per Share	-2.33

Full Cash Flow Statement

Margins

Gross margin is 27.09%, with operating and profit margins of -505.80% and -257.64%.

Gross Margin	27.09%
Operating Margin	-505.80%
Pretax Margin	-286.69%
Profit Margin	-257.64%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6617 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.64%
Shareholder Yield	-6.64%
Earnings Yield	-0.79%
FCF Yield	-2.81%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6617 has an Altman Z-Score of 36.95.

Altman Z-Score	36.95
Piotroski F-Score	n/a